重要的是，在对比的是24周的分析，一个重要的优势是体现在分组病人谁也收到恩夫韦地作为一个新药方案；

Importantly, in contrast to the 24-week analysis, a significant benefit was seen in the subgroup of patients who also received enfuvirtide as a new agent in the regimen;

youdao

重要的是，在对比的是24周的分析，一个重要的优势是体现在分组病人谁也收到恩夫韦地作为一个新药方案；

Importantly, in contrast to the 24-week analysis, a significant benefit was seen in the subgroup of patients who also received enfuvirtide as a new agent in the regimen;

youdao